A.O.U. Maggiore della Carità

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Type 2 diabetes

Closed trials

• Completed

  DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy

  NCT05755360· Novo Nordisk A/S· Source